Skip to main content

CITADEL ADVISORS LLC

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in OTLK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
6 quarters on record

Derivatives in OTLK

reported options exposure · as of Mar 31, 2026
CallValue
$23,422
CallShares
113,700
PutValue
$16,644
PutShares
80,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,644 80,800
2026-03-31 $23,422 113,700
2025-12-31 $191,654 121,300
2025-12-31 $1,450,914 918,300
2025-09-30 $18,232 17,200
2025-09-30 $30,316 28,600
2025-03-31 $47,702 39,100
2024-12-31 $63,126 33,400
2024-12-31 $16,427 8,692
2024-12-31 $945 500
2024-09-30 $397,296 74,400